Back to Results
First PageMeta Content
Health / Meningococcal disease / Asplenia / Meningococcal vaccine / Pneumococcal conjugate vaccine / Vaccination schedule / Vaccination / NmVac4-A/C/Y/W-135 / Pneumococcal polysaccharide vaccine / Vaccines / Medicine / Biology


A Quick Look at Using Meningococcal Conjugate Vaccines (MCV4)
Add to Reading List

Document Date: 2013-04-26 14:51:34

Open Document

File Size: 259,14 KB

Share Result on Facebook

City

Mecca / /

Company

Novartis / MCV41 (Meningococcal Conjugate Vaccine) Age Subgroup / MCV4 / /

IndustryTerm

travel to/living / travel/outbreak / risk / /

MedicalCondition

HIV infection / Meningococcal Disease / persistent terminal complement deficiency / HIV / disease / invasive pneumococcal disease / Persistent complement component deficiency / /

MedicalTreatment

immunization / vaccination / /

Organization

Vaccine Administration / /

Position

Microbiologist / /

Technology

CRM / /

URL

www.cdc.gov/vaccines / www.michigan.gov/immunize / www.cdc.gov/vaccines/recs / /

SocialTag